Home › CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C
 

Keywords :   


CEO Frazier: Merck is eager for deals, sees strong prospects for drugs for cancer, hepatitis C

2016-01-05 22:22:53| Biotech - Topix.net

Merck's chief executive says the drugmaker is "raring to go" on deals this year, particularly for small and midsize acquisitions of companies or their experimental drugs. CEO Kenneth Frazier, speaking Tuesday at a Goldman Sachs conference of CEOs of health care companies in Boston, also said he expects more approvals and growing sales from new cancer drug Keytruda.

Tags: strong deals cancer drugs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Dabbagh Named General Manager of Waldencast Ventures Glaze Brand
20.05BT scraps digital landline switch deadline
20.05Essie Introduces Nail Art Studio
20.05Ilia Beauty Introduces Vegan Lip Sketch Hydrating Crayon
20.05Summer interest rate cut possible, says Bank deputy
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Farm Progress America, May 20, 2024
More »